SEARCH

SEARCH BY CITATION

References

  • Adams R. D., van Bogaert L. and van der Eecken H. (1961) Dégénérescences nigro-striées et cérébello-nigro-striées. Psychiatria Neurol. 142, 219259.
  • Alali F. Q., Liu X.-X. and McLaughlin J. L. (1999) Annonaceous acetogenins: recent progress. J. Nat. Prod. 62, 504540.
  • Albers D. S. and Augood S. J. (2001) New insights into progressive supranuclear palsy. Trends Neurosci. 24, 347353.
  • Albers D. S. and Beal M. F. (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural. Transm. Suppl. 59, 133154.
  • Albers D. S., Swerdlow R. H., Manfredi G., Gajewski C., Yang L., Parker W. D. Jr and Beal M. F. (2001) Further evidence for mitochondrial dysfunction in progressive supranuclear palsy. Exp. Neurol. 168, 196198.
  • Albin R. L. (2000) Basal ganglia neurotoxins. Neurol. Clin. 18, 665680.
  • Beal M. F., Brouillet E., Jenkins B., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R. and Hyman B. T. (1993) Neurochemical and histological characterization of the striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitroproprionic acid. J. Neurosci. 13, 14811492.
  • Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 13011306.
  • Bhatt M. H., Elias M. A. and Mankodi A. K. (1999) Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases. Neurology 52, 14671471.
  • Bindoff L. A., Birch-Machin M., Cartlidge N. E., Parker W. D. Jr and Turnbull D. M. (1989) Mitochondrial function in Parkinson's disease. Lancet 2, 49.
  • Borlongan C. V., Koutouzis T. K., Freeman T. B., Hauser R. A., Cahill D. W. and Sanberg P. R. (1997) Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitroproprionic acid model. Brain Res. Protocols 1, 253257.
  • Brouillet E., Jenkins B., Hyman B., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356359.
  • Caparros-Lefebvre D. and Elbaz A. (1999) Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case–control study. Caribbean Parkinsonism Study Group. Lancet 354, 281286.
  • Caparros-Lefebvre D., Sergeant N., Lees A., Camuzat A., Daniel S., Lannuzel A., Brice A., Tolosa E., Delacourte A. and Duyckaerts C. (2002) Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy. Brain 125, 801811.
  • Daniel S. E., de Bruin V. M. S. and Lees A. J. (1995) The clinical and pathological spectrum of Steele–Richardson–Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 118, 759770.
  • DiDonato S., Zeviani M., Giovannini P., Savarese N., Rimoldi M., Mariotti C., Girotti F. and Caraceni T. (1993) Respiratory chain and mitochondrial DNA in muscle and brain in Parkinson's disease patients. Neurology. 43, 22622268.
  • Ehringer H. and Hornykiewicz O. (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin. Wochenschrift 38, 12361239.
  • Fearnley J. M. and Lees A. J. (1990) Striatonigral degeneration. A clinicopathological study. Brain 113, 18231842.
  • Ferrante R. J., Schulz J. B., Kowall N. W. and Beal M. F. (1997) Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra. Brain Res. 753, 157162.
  • Glinka Y. Y. and Youdim M. B. (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. 292, 329332.
  • Guyot M.-C., Hantraye P., Dolan R., Palfi S., Maziere M. and Brouillet E. (1997) Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79, 4556.
  • Hamilton B. F. and Gould D. H. (1987) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol. 72, 286297.
  • Hirsch E. C., Orieux G., Muriel M. P., Francois C. and Féger J. (2002) Non-dopaminergic neurons in Parkinson's disease. In: Advances in Neurology (A. Gordeni, S. Kaakkola and H. Teráväinen, eds), pp. 2337. Lippincott Wiliams & Wilkins, Philadelphia.
  • Javitch J. A., D'Amato R. J., Strittmatter S. M. and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl Acad. Sci. USA 82, 21732177.
  • Jellinger K. A. (1999) Post-mortem studies in Parkinson's disease: is it possible to detect brain areas for specific symptoms? J. Neural. Transm. Suppl. 56, 129.
  • Jellinger K. A. (2001) Pathology of Parkinson's disease. In: Parkinson's Disease: Advances in Neurology (Calne, D., Calne, S. M., eds), Vol. 86, pp. 5572. Lippincott Williams & Wilkins, Philadelphia.
  • Kawamoto J. C. and Barrett J. N. (1986) Cryopreservation of primary neurons for tissue culture. Brain Res. 384, 8493.
  • Lockwood A. H. (2000) Pesticides and parkinsonism: is there an etiological link? Curr. Opin. Neurol. 13, 687690.
  • Mann V. M., Cooper J. M., Krige D., Daniel S. E., Schapira A. H. and Marsden C. D. (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115, 333342.
  • Michel P. P. and Agid Y. (1996) Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J. Neurochem. 67, 16331642.
  • Muriel M. P., Bernard V., Levey A. I., Laribi O., Abrous D. N., Agid Y., Bloch B. and Hirsch E. C. (1999) Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann. Neurol. 46, 103111.
  • Nicklas W. J., Vyas I. and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36, 25032508.
  • Parker W. D., Boyson S. J. and Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719723.
  • Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B. and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
  • Schapira A. H., Mann V. M., Cooper J. M., Dexter D., Daniel S. E., Jenner P., Clark J. B. and Marsden C. D. (1990) Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease. J. Neurochem. 55, 21422145.
  • Simon D. K., Pulst S. M., Sutton J. P., Browne S. E., Beal M. F. and Johns D. R. (1999) Familial multisystem degeneration with parkinsonism associated with the 11778 mitochondrial DNA mutation. Neurology 53, 17871793.
  • Steele J. C., Richardson J. C. and Olszewski J. (1964) Progressive supranuclear palsy. A heterogeneous degeneration involving the brainstem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol. 10, 333359.
  • Swerdlow R. H., Golbe L. I., Parks J. K., Cassarino D. S., Binder D. R., Grawey A. E., Litvan I., Bennett J. P. Jr, Wooten G. F. and Parker W. D. (2000) Mitochondrial dysfunction in cybrid lines expressing mitochondrial genes from patients with progressive supranuclear palsy. J. Neurochem. 75, 16811684.
  • Waddington J. L. (1980) Effects of nomifensine and desipramine on the sequelae of intracerebrally-injected 6-OHDA and 5,6-DHT. Pharmacol. Biochem. Behav. 13, 915917.
  • Windholz M., Budavari S., Stroumtsos L. Y. and Fertig M. N., eds. (1976) The Merck Index. An Encyclopedia of Chemicals and Drugs, 9th edn. Merck, Rahway, NJ, pp. 10711072.
  • Wüllner U., Young A., Penney J. and Beal M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 17721781.